Clinical Trial

Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Name: Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) — clinical trial record (NCT06134414)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The main purpose of this study is to evaluate the efficacy of MY008211A in adult patients with PNH, showing signs of active hemolysis.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2023-11-10; most recent amendment 2025-07-27.

Trial Details

NCT Number	NCT06134414
Lead Sponsor	Wuhan Createrna Science and Technology Co., Ltd
Conditions	Paroxysmal Nocturnal Hemoglobinuria (PNH)
Enrollment	40 participants
Start Date	2025-12
Primary Completion	2027-07 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-07-29